Network Version
Lagociclovir Data Sheet
| Product Name: | Lagociclovir |
 |
|---|---|---|
| CAS No.: | 92562-88-4 | |
| Cat. No.: | HY-14844 | |
| MWt: | 269.23 | |
| Formula: | C10H12FN5O3 | |
| Purity : | >98% | |
| Solubility: | 10 mM in DMSO | |
| Mechanisms: | Target: Infection | |
| Biological Activity: | ||
|
Lagociclovir (FLG) is a nucleoside analogue that inhibits wild-type hepatitis B virus (HBV) replication in a human hepatoma cell line permanently expressing HBV[1].
IC50 & Target:HBV[1]
In Vitro:Lagociclovir (FLG) (6 days) shows inhibitory activity with IC50s of 8 ± 3.8, 9 ± 2.5, 13 ± 3.4 and 15 ± 6.8 μM against 3TC-R HBV, wt HBV, PMEA-R HBV and 3TC+PMEA-R HBV, respectively in transiently transfected Huh7 cells[1]. Lagociclovir (0-100 μM; 6 days) inhibits the replication of wild-type and drug-resistant mutants of HBV in transiently transfected Huh7 cells[1]. |
||
1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA
Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected] Web:www.medchemexpress.com